AMSEL MEDICAL CORPORATION

Amsel Medical Corporation specializes in the design and development of advanced medical devices for critical care applications, with a focus on percutaneous, non-surgical interventions for life-threatening hemorrhage. Their technical expertise centers on minimally invasive vascular occlusion systems, leveraging precision engineering and real-time adjustable delivery mechanisms to control junctional and non-compressible bleeding in battlefield and trauma settings. The company demonstrates deep proficiency in biomedical device prototyping, interventional hemostasis technologies, and translational research from bench to battlefield, with a clear emphasis on rapid deployment and field usability under extreme conditions. Their innovation lies in the integration of catheter-based, deployable occlusion platforms that offer dynamic control without surgical exposure—setting them apart in the domain of tactical medical countermeasures. Amsel Medical has delivered research and development solutions to the Department of Defense, specifically addressing urgent warfighter medical needs through defense-funded biomedical innovation programs. Their engagement reflects a targeted partnership with military medical research entities focused on enhancing survivability in pre-hospital and combat environments, indicating a strong alignment with DOD’s Combat Casualty Care priorities and the Trauma and Combat Casualty Research Program. The company’s primary industry focus is in research and development within the life sciences, specifically in the design of novel medical devices for acute hemorrhage control. This vertical specialization positions them at the intersection of biomedical engineering and military medicine, serving a niche but critical segment of the defense and emergency medical technology market. Amsel Medical Corporation is a small business entity based in Cambridge, Massachusetts, with no federal certifications on record. Their geographic presence in the Greater Boston biotech corridor supports close collaboration with academic medical centers and defense research institutions, reinforcing their role as a specialized innovator in advanced medical device development for government-sponsored programs.